Lorena Taricani - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lorena Taricani

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Journal of Virology|September 29, 2004

Anti-Vpr activity of a yeast chaperone proteinZsigmond Benko, Dong Liang, Emmanuel Agbottah, et al.

Molecular Cancer Therapeutics|February 16, 2011

Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screeningTimothy J Guzi, Kamil Paruch, Michael P Dwyer, et al.

Bioorganic & Medicinal Chemistry|March 5, 2014

The identification of novel 5'-amino gemcitabine analogs as potent RRM1 inhibitorsMarc A Labroli, Michael P Dwyer, Ruichao Shen, et al.

ACS Medicinal Chemistry Letters|January 16, 2015

Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR InhibitorsPaul A Barsanti, Yue Pan, Yipin Lu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Journal of Virology|September 29, 2004

Anti-Vpr activity of a yeast chaperone proteinZsigmond Benko, Dong Liang, Emmanuel Agbottah, et al.

Molecular Cancer Therapeutics|February 16, 2011

Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screeningTimothy J Guzi, Kamil Paruch, Michael P Dwyer, et al.

Bioorganic & Medicinal Chemistry|March 5, 2014

The identification of novel 5'-amino gemcitabine analogs as potent RRM1 inhibitorsMarc A Labroli, Michael P Dwyer, Ruichao Shen, et al.

ACS Medicinal Chemistry Letters|January 16, 2015

Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR InhibitorsPaul A Barsanti, Yue Pan, Yipin Lu, et al.

Pageof 2